Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies
β Scribed by I. Byrjalsen; D. J. Leeming; P. Qvist; C. Christiansen; M. A. Karsdal
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 400 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0937-941X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Denosumab, a fully human monoclonal antibody to RANKL, decreases bone remodeling, increases bone density, and reduces fracture risk. This study evaluates the time course and determinants of bone turnover marker (BTM) response during denosumab treatment, the percentage of denosumabβtreat
## Abstract This randomized, doubleβblind, placeboβcontrolled, doseβresponse late phase 2 study evaluated the efficacy and safety of bazedoxifene in postmenopausal Japanese women 85 years of age or younger with osteoporosis. Eligible subjects received daily treatment with oral doses of bazedoxifene